It's not through a want of effort or trying that the incumbents have not penetrated the Aortic Stenosis market as deeply as they'd have liked although the LIMITATIONS of the devices that they're marketing.
The DurAVR smashes the current incumbents devices across all the parameters currently measured and even one that wasn't! (Until Anteris and their doctors started measuring it... laminar flow.)
Which is perhaps the most important of all measurements as it's the best indicator of valve performance, i.e. when laminar flow is perfect, valve performance is perfect.
So.... exciting months ahead!
AVR Price at posting:
$21.95 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
